Related Experiment Video
Updated: Jan 27, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.5K
A Pediatric Case of Narcolepsy Presenting as Syncope
Jeffrey A Miskoff1, Moiuz Chaudhri1
1Internal Medicine, Jersey Shore University Medical Center, Neptune City, USA.
Cureus
|March 15, 2019
Summary
Narcolepsy, a chronic sleep disorder from protein deficiency, disrupts circadian rhythms and sleep architecture. Early diagnosis and treatment are crucial for managing this condition and improving patient quality of life.
Area of Science:
- Neurology
- Sleep Medicine
- Genetics
Background:
- Narcolepsy is a chronic, genetic sleep disorder linked to protein deficiency.
- It impacts sleep architecture and the brain's circadian rhythm control.
- Symptoms include daytime sleepiness despite feeling rested upon waking.
Observation:
- Onset typically occurs in adolescence.
- A significant delay in diagnosis is common.
- This delay can severely impact an individual's quality of life.
Findings:
- The case highlights an underdiagnosed condition.
- Timely diagnosis and aggressive off-label therapy were key.
- The individual achieved success despite the disorder.
Implications:
- This case underscores the importance of recognizing narcolepsy symptoms.
- Prompt diagnosis and treatment can significantly improve outcomes.
- It emphasizes the potential of off-label therapies for narcolepsy management.
Keywords:
case reportcataplexyexcessive daytime sleepinessmultiple sleep latency testnarcolepsynocturnal polysomnogramorexin/hypocretinphysicssleep disordersodium oxybateMore Related Videos
Related Concept Videos
01:07Narcolepsy
543
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
543
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
271
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271